GLN-ATOVAQUONE
GLN-ATOVAQUONE
Approved
DIN Number
02528495
Drug Class
Human
Market Date
Jun 30, 2022
Company
HC
glenmark pharmaceuticals canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02528495
AIG Number0124073001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
P01AX06 ATOVAQUONE
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification08:30.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ATOVAQUONEActive
Strength: 750 MG / 5 ML
Monograph: ATOVAQUONE